Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Medicus Pharma Ltd (MDCX) had Return on Tangible Equity of -355.87% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-11.16M |
|
-- |
|
-- |
|
$11.18M |
|
$-11.18M |
|
$0.03M |
|
$-11.16M |
|
$-11.16M |
|
$-11.16M |
|
$-11.16M |
|
$-11.16M |
|
$-11.16M |
|
$-11.18M |
|
$-11.18M |
|
9.62M |
|
9.62M |
|
$-1.16 |
|
$-1.16 |
|
| Balance Sheet Financials | |
$5.38M |
|
-- |
|
$0.27M |
|
$5.65M |
|
$2.31M |
|
-- |
|
$0.21M |
|
$2.51M |
|
$3.13M |
|
$3.13M |
|
$3.13M |
|
11.82M |
|
| Cash Flow Statement Financials | |
$-10.25M |
|
-- |
|
$12.69M |
|
$1.72M |
|
$4.16M |
|
$2.44M |
|
$0.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-355.87% |
|
|
Return on Tangible Equity |
-355.87% |
-197.55% |
|
-355.87% |
|
$0.27 |
|
$-1.07 |
|
$-1.07 |
|